Expert predicts warfarin to become obsolete

The US study in 250 patients receiving long-term stable doses of warfarin showed that INR monitoring every 12 weeks was as safe as monitoring INR every four weeks.

Patients who had monitoring with the longer interval were in the therapeutic range 74% of the time, compared with 72% for those monitored at shorter intervals.